A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Safety and Efficacy of Onradivir Tablets in Participants Aged 12 to 17 Years With Uncomplicated Influenza A.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Related studies linked through entity extraction aliases.